opb-31121
Small moleculeexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2007 (NCT00511082)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
STAT3 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- opb 31121
- opb-31121
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01406574 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2011 | Otsuka |
| NCT00955812 | Phase 1 | Jun 1, 2009 | Otsuka, University of Texas at Houston |
| NCT01029509 | Phase 1 | Jul 1, 2008 | Otsuka, University of Texas at Houston |
| NCT00657176 | Phase 1 | Mar 1, 2008 | Otsuka, Seoul National University |
| NCT00511082 | Phase 1 | Dec 1, 2007 | City University of Hong Kong, Otsuka |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Otsuka | For profit | 5 | 3 | 2 | 2007 |
| University of Texas at Houston | Academic/Hospital | 2 | 2 | 1 | 2008 |
| City University of Hong Kong | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2008 |
4 organizations
Page 1 / 1